Merck researcher Max Tishler
Former President of MS&D Labs Max Tishler, PhD, died March 18. At MS&D, he was the leader of research programs that developed drugs for heart disease, hypertension, arthritis, mental depression and infectious diseases. Tishler "established the pattern for biomedical research at Merck," the firm said in a release. Merck noted that Tishler led the Merck group that developed a production process for penicillin. The researcher was also an emeritus University Professor of the Sciences at Wesleyan University. In recognition of his contributions, Tishler was awarded the National Medal of Science in June 1987.
You may also be interested in...
Companies marketing dexamethasone in Europe have been told they can use a CHMP endorsement to request the addition of COVID-19 to their product license.
Redirection of healthcare resources to tackle COVID-19 is posing huge challenges for TB care and researchers in the area. Companies like J&J have stepped in to support, among other aspects, innovative community-based solutions to ensure continuity of care for drug resistant-TB patients amid the pandemic.
After a high-profile launch early this year, first-mover Perrigo has recalled its albuterol sulfate aerosol in the US following complaints of inhalers failing to dispense due to “clogging.” The firm has revealed the expected financial impact of the move as well as commenting on how long it expects the product to be off the market, during which albuterol rivals Cipla and Lupin could benefit.